Shell Asset Management CO Soma Logic, Inc. Transaction History

Shell Asset Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $6,747 - $10,850	-3,834 Reduced 22.89%	12,914 $33,000
Q3 2023 Nov 08, 2023	SELL	$1.99 - $2.45 $127 - $156	-64 Reduced 0.38%	16,748 $40,000
Q2 2023 Jul 28, 2023	SELL	$2.1 - $3.36 $201 - $322	-96 Reduced 0.57%	16,812 $39,000
Q1 2023 May 15, 2023	SELL	$2.13 - $3.6 $125 - $212	-59 Reduced 0.35%	16,908 $43,000
Q4 2022 Feb 07, 2023	SELL	$2.05 - $3.47 $1,970 - $3,334	-961 Reduced 5.36%	16,967 $43,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $1,498 - $13,013	-2,379 Reduced 11.72%	17,928 $52,000
Q2 2022 Aug 09, 2022	BUY	$4.27 - $8.26 $86,710 - $167,735	20,307 New	20,307 $92,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.